Correlation Between Hain Celestial and Integrated Biopharma
Can any of the company-specific risk be diversified away by investing in both Hain Celestial and Integrated Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hain Celestial and Integrated Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between The Hain Celestial and Integrated Biopharma, you can compare the effects of market volatilities on Hain Celestial and Integrated Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hain Celestial with a short position of Integrated Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hain Celestial and Integrated Biopharma.
Diversification Opportunities for Hain Celestial and Integrated Biopharma
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Hain and Integrated is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding The Hain Celestial and Integrated Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integrated Biopharma and Hain Celestial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on The Hain Celestial are associated (or correlated) with Integrated Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integrated Biopharma has no effect on the direction of Hain Celestial i.e., Hain Celestial and Integrated Biopharma go up and down completely randomly.
Pair Corralation between Hain Celestial and Integrated Biopharma
Given the investment horizon of 90 days The Hain Celestial is expected to under-perform the Integrated Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, The Hain Celestial is 2.19 times less risky than Integrated Biopharma. The stock trades about -0.03 of its potential returns per unit of risk. The Integrated Biopharma is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest 38.00 in Integrated Biopharma on August 28, 2024 and sell it today you would lose (5.00) from holding Integrated Biopharma or give up 13.16% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 31.52% |
Values | Daily Returns |
The Hain Celestial vs. Integrated Biopharma
Performance |
Timeline |
Hain Celestial |
Integrated Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Hain Celestial and Integrated Biopharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Hain Celestial and Integrated Biopharma
The main advantage of trading using opposite Hain Celestial and Integrated Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hain Celestial position performs unexpectedly, Integrated Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrated Biopharma will offset losses from the drop in Integrated Biopharma's long position.Hain Celestial vs. J J Snack | Hain Celestial vs. Lancaster Colony | Hain Celestial vs. Treehouse Foods | Hain Celestial vs. Simply Good Foods |
Integrated Biopharma vs. Premier Foods Plc | Integrated Biopharma vs. Torque Lifestyle Brands | Integrated Biopharma vs. Naturally Splendid Enterprises | Integrated Biopharma vs. Aryzta AG PK |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |